Understanding Your Cancer Diagnosis Letter: Breaking Down What Your Oncologist Wrote and What You Should Ask

A cancer diagnosis letter (sometimes called an oncology clinic letter or a pathology report cover letter) is your care team's written account of what your tests, scans, and tissue biopsy found. Most letters cover six key things: your cancer type, how the cells look under a microscope, grade, stage, margin status if surgery was done, and molecular test results. Knowing what each section means helps you walk into your next appointment ready to ask the right questions.

These letters use shorthand, abbreviations, and Latin-rooted terms that can stop most readers mid-sentence. That doesn't mean the information is beyond you - it just means you need a brief guide before sitting down with the document. This article provides exactly that.

If you want to understand the broader picture of what happens right after a diagnosis, the first 72 hours after a cancer diagnosis guide covers the full sequence of tests and decisions you are likely to face early on.

What Is a Cancer Diagnosis Letter?

When a specialist reviews your imaging, blood tests, and biopsy, they write up their findings in a formal document. In many healthcare systems, this document goes to your primary care doctor, which is why the language tends to be clinical and dense rather than patient-facing. What you receive - whether by post, email, or through a patient portal - is often a version of this same report.

The National Cancer Institute describes the pathology report as serving three core purposes: confirming the cancer diagnosis, helping to stage the cancer (describing how widely it has spread in the body), and guiding treatment planning. Your diagnosis letter is built around those three goals.

One thing worth knowing: many hospitals now release test results directly into patient portals at the same moment the physician receives them. You may read your letter before your oncologist has had a chance to call you. If that happens, resist drawing firm conclusions until you have spoken with your care team. Use the letter as an input to a conversation - not the final word on your situation.

The Six Main Parts of a Cancer Diagnosis Letter

Most oncology letters follow a recognisable structure. Here is what each part tells you.

1. Primary Diagnosis

This is the single most important line in the letter. It names the exact cancer type - for example, invasive ductal carcinoma for a common form of breast cancer, or squamous cell carcinoma for a type of skin cancer. Each cancer type has its own biology, behaviour, and treatment options. The primary diagnosis is the foundation on which every treatment recommendation is built, so make sure your oncologist explains it to you in plain language if anything about it is unclear.

2. Histology

Histology is the examination of tissue under a microscope. The histology section of your letter describes what your cancer cells actually look like. You may see the term well-differentiated - meaning the cells resemble the normal tissue they came from. Poorly differentiated or undifferentiated means the cells look very abnormal. This matters because cells that look more abnormal tend to behave more aggressively, and that shapes what treatments your team may consider.

3. Tumour Grade

Grade is related to histology. It's a number - usually on a scale of 1 to 3 or 1 to 4 - that describes how abnormal the cancer cells look and how quickly they might grow. The American Cancer Society explains that a grade 1 tumour has cells that look relatively close to normal and may grow slowly, while a grade 3 or 4 tumour has highly abnormal cells that may grow or spread more quickly. Grade is one of several factors your oncologist weighs when recommending how soon and how aggressively to treat.

4. Stage and the TNM System

Stage describes how far cancer has spread in your body. Most solid tumours are staged using the TNM system, where T stands for the size and extent of the primary tumour, N for whether cancer has reached nearby lymph nodes, and M for whether cancer has spread - also called metastasis - to distant organs. The National Cancer Institute explains that each letter is paired with a number (for example, T2 N0 M0) and these combine to produce an overall stage from I (localised) to IV (spread to other parts of the body).

Stage describes where things are right now, not a fixed prediction of outcome. For a more detailed explanation of what each stage number means in practice, this plain-English guide to cancer staging and TNM classification goes through each component in detail.

5. Surgical Margins

If you have already undergone surgery to remove a tumour, the letter will include a margins section. A negative margin means the pathologist found no cancer cells at the outer edge of the removed tissue - a sign the surgeon was able to remove the visible tumour. A positive margin means cancer cells were found at the edge, which your oncologist will discuss with you in terms of what comes next. This section only appears in letters written after a surgical procedure.

6. Molecular and Receptor Status

This is one of the most clinically significant parts of a modern diagnosis letter, and one of the most confusing for patients seeing it for the first time. Molecular testing looks at specific proteins, gene mutations, and markers on or inside your tumour cells. The results may include receptor status - for example, in breast cancer, whether cells test positive or negative for oestrogen receptor (ER), progesterone receptor (PR), or the HER2 protein. In lung cancer, results may include whether the tumour carries gene mutations such as EGFR or ALK that targeted therapies may address.

These results matter for treatment decisions. They can determine whether certain treatment classes are considered at all. If your letter includes biomarker or receptor results, ask your oncologist to walk through each one and explain what it means for your specific options.

Common Terms and What They Mean

Here is a short glossary of words that appear frequently in diagnosis letters.

• Malignant: Cancerous. The cells have the ability to invade surrounding tissue or spread to other parts of the body.
• Benign: Not cancerous. Benign findings still need follow-up, but they do not spread the way cancer does.
• In situ: From Latin, meaning in place. Cancer cells are present but have not yet invaded the surrounding tissue layer. This typically reflects an earlier stage of cancer development.
• Invasive: Cancer cells have moved beyond the tissue layer where they started.
• Metastasis / metastatic: Cancer that has spread from where it started to a different part of the body.
• Ki-67: A marker that reflects how rapidly cancer cells are dividing. A higher percentage generally suggests faster growth.
• Lymphovascular invasion (LVI): Cancer cells found inside nearby blood or lymph vessels. This may suggest a slightly higher risk that cancer has spread.
• Adjuvant therapy: Treatment given after primary treatment - usually surgery - to reduce the chance of recurrence.
• Neoadjuvant therapy: Treatment given before primary treatment, typically to shrink a tumour before surgery.
• Resection: Surgical removal of the tumour or a part of it.

What to Do When the Letter Arrives

Read the letter once all the way through before your appointment. Have a pen and notepad beside you. Circle or write down every term or phrase you don't recognise - you don't need to look each one up immediately, but having the list means you won't forget what confused you when you are sitting across from your doctor.

If the letter arrived through a patient portal before you have spoken to your oncologist, it's reasonable to send a short message to your care team letting them know you have read the results and asking when you can discuss them. Most cancer centres aim to follow up with patients quickly after test results are released.

Consider bringing a trusted person to your appointment - a family member, friend, or caregiver. Having a second person in the room helps patients retain what is discussed and catch details they might miss under stress. If in-person support is not possible, many oncology teams now allow a family member to join the consultation by phone or video.

Reading the Letter as a Caregiver

If you are a caregiver who received or found the diagnosis letter on behalf of a patient who cannot review it themselves - because of illness, language barriers, age, or emotional overwhelm - you are doing something important. Your job right now is to understand the key findings well enough to ask good questions on the patient's behalf, not to interpret the medical conclusions on your own.

Focus on the same six sections above: primary diagnosis, histology, grade, stage, margins (if applicable), and molecular status. Note anything that seems inconsistent with what the medical team said verbally. Write down the questions the patient would want answered if they could. Then ask the oncologist how much detail the patient would like to receive - different patients want different amounts of information, and the care team can help calibrate that.

When the Letter Raises Doubts

Your diagnosis letter reflects the findings available at the time it was written. Oncology is a highly specialised field, and for complex cases - unusual tumour types, ambiguous staging findings, or nuanced molecular profiles - expert opinions can sometimes differ. That is not a failure of medicine; it reflects how much expertise the field requires.

A systematic review on patient-driven second opinions in oncology found that specialist review leads to meaningful changes in diagnosis or management recommendations for many patients who seek one. A second opinion does not mean your first doctor made a mistake - it means you are being thorough at a moment when thoroughness matters. In many cases, a second review confirms the original plan, which gives you confidence to move forward.

If your letter contains a rare cancer type, complex molecular results, or staging details that weren't clearly explained to you, the case for a specialist second opinion is strong. This article on seeking a second opinion even when treatment feels urgent walks through the timing and process.

Questions to Ask Your Oncologist About Your Letter

The American Cancer Society and Memorial Sloan Kettering Cancer Center both recommend that patients come to appointments with written questions. Here is a starting list.

• Can you explain my primary diagnosis in plain language - what does it mean for how my body is affected?
• What do my tumour grade and stage tell us about how this cancer typically behaves?
• Are there any molecular or receptor results in my letter that affect which treatments may be considered?
• What additional tests, if any, still need to be done before a treatment plan can be finalised?
• What are the main treatment options being considered for my cancer type and stage?
• How soon does treatment need to start, and is there time for me to seek a second opinion or consider my options?
• Will my case be reviewed by a multidisciplinary tumour board?
• Who is the best person on the team to contact if I have questions between appointments?

For a more detailed checklist broken down by topic - covering diagnosis, treatment logistics, and what to bring with you - the full patient checklist for your first oncologist appointment is a practical companion to this guide.

Getting Expert Input Without Travelling

If you want a second specialist's perspective on your diagnosis letter but attending another centre in person is not practical - because of distance, cost, or timing - an online consultation is a workable option. Through HealthUnwired, you can upload your diagnosis letter, pathology reports, and imaging results securely and connect with a verified oncologist by video, often within 48 hours. The oncologist reviews your full file before the call and provides a written opinion you can take back to your treating team. No travel is required.

This kind of remote review is particularly useful when your letter contains complex molecular findings, when your cancer type is less common and you want to hear from a specialist in it, or when you want to be confident about a recommended treatment plan before you commit to it.

When to Talk to Your Doctor

Contact your oncology team promptly if: your letter describes a high grade or advanced stage and no follow-up appointment has been scheduled; your letter contains biomarker or molecular test results that weren't explained to you; you notice a difference between what you were told verbally and what the letter says; or the language in the letter is so unfamiliar that you cannot form useful questions without guidance. Your care team expects these calls - asking for clarity is part of the process.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.